Eric Larsen, DPM
Podiatrist · Creston, IANPI 1912293135
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Amgen at 42.5% of the total. Reporting peaked in 2019 at $6,244 and has fallen 90.0% since, to $626 in 2025.
Across 103 payments — averaging $99.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- Stryker$1K
- Arthrex$1K
- Johnson & Johnson$1K
- Medical Device Business Services, Inc.$942
- Smith+Nephew$169
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$3,00029%
- Travel & lodging$2,63326%
- Food & beverage$3,48034%
- Education$1,08511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $4,331 |
| Stryker(2 entities) | 32 | $1,387 |
| Arthrex | 3 | $1,113 |
| Johnson & Johnson | 9 | $1,084 |
| Medical Device Business Services, Inc. | 6 | $942 |
| Smith+Nephew | 8 | $169 |
| Mimedx Group, Inc. | 1 | $169 |
| Acell, Inc. | 1 | $124 |
| Paragon 28, Inc. | 4 | $119 |
| Integra Lifesciences Corporation | 3 | $118 |
| Zimmer Biomet | 5 | $97 |
| Sebela Pharmaceuticals Inc. | 2 | $84 |
| Merck | 1 | $83 |
| Organogenesis Inc. | 4 | $65 |
| Ossio Inc | 1 | $52 |
| Globus Medical | 1 | $44 |
| DJO, LLC | 2 | $40 |
| Kerecis Limited | 1 | $32 |
| Urgo Medical North America, LLC | 1 | $28 |
| Reprise Biomedical, Inc. | 1 | $23 |
| Medtronic | 1 | $23 |
| Misonix Inc | 1 | $21 |
| Linvatec Corporation | 1 | $20 |
| Hydrofera LLC | 1 | $18 |
| Solventum Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$4,062
- MOTOBAND$748
- AUGMENT INJECTABLE$312
- 7 X 23MM CITRELOCK IMPLANT$174
- ORTHOLOC 3DI$132
How this compares
$10,198 in reported general payments places this provider in the 85th percentile of 94 podiatrist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 23 | $482 |
| Allopurinol | 49 | $301 |
| Methylprednisolone | 22 | $121 |
| Cephalexin | 18 | $110 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $60 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Creston
- Paul DaytonAnkeny$9.4M
- Mindi DaytonAnkeny$333K
- Eric BarpWest Des Moines$149K
- Travis TidwellWaterloo$33K
- Eric TempleWest Des Moines$19K
- Eric JensenCarroll$17K
- Eric ReeseWest Des Moines$14K
- Andrew StanislavCouncil Bluffs$13K
- Jeffrey KileyCouncil Bluffs$12K
- Ronald KaneWaterloo$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.